The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
The Health and Economic Benefits Possible with Novel Tuberculosis Vaccines – A Modeling Study in India and Indonesia.Tuesday, July 16, 2024Available, demand assessedRead More
Mixed vaccination strategy for the control of tuberculosis: A case study in China.Tuesday, July 16, 2024Available, demand assessedRead More
Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India.Tuesday, July 16, 2024Available, demand assessedRead More
